Patent Landscape Report For Pegylated Interferon Alfa 2A & 2B
Voluntary Licensing: Optimizing Global Efforts And Measuring Impact, I-MAK/ITPC
For the past decade, pharmaceutical companies have increasingly used voluntary licenses to allow generic production of patented antiretroviral drugs for People Living with HIV/AIDS in poor countries. However, these licenses have not been pursued optimally from a public health standpoint. This paper will comment on the current efforts of global health institutions and propose a…
Evaluating The Potential Impact Of Aurobindo’s Unbundling
Examination of the potential benefit, if any, of Aurobindo’s decision to opt out of the MPP-Gilead license for TDF.
Financial Impact Of The Medicines Patent Pool: I-MAK/ITPC Counter Analysis
We prepared the following analysis as a response to claims made by the MPP about its economic benefits.
Measuring the Impact of Medicines Patent Pool Licenses: A Civil Society Assessment
Why UNITAID Matters for People Living with HIV/AIDS, TB and Malaria – Market Impact Report by the Civil Society Delegations Civil Society Assessment Presentation
Briefing Paper: Analysis Of The Patent Pool Licenses
Briefing Memo: Risks Of The Trans-Pacific Free Trade Agreement For Access To Medicines – Analysis Of The Leaked U.S. Paper Eliminating Patent Pre-Grant Opposition
A leaked U.S. paper recently circulated to countries negotiating the TransPacific Partnership Agreement (TPPA) outlines the U.S. argument for eliminating “pre-grant opposition,” an important tool for preventing patent applicants from gaining patent monopolies based on weak or erroneous information, for improving the quality and efficiency of patent office examinations, and for safeguarding access to medicines.
HIV Drug Patents in China – A Patent Landscape
This report focuses on the HIV drug patent landscape in China. The patents included this landscape include key ARV patents that are likely to have a bearing on procurement decisions in China.
India and Second-Line ART, Evaluating the Way Forward, INP+ Discussion Paper
This discussion paper was commissioned by the Indian Network for People Living with HIV/AIDS (INP+) to address the feasibility of introducing second-line ART into NACO’s public-sector treatment programme.
Urgent Need for Second-Line HIV Treatment
Radhakrishnan and Abraham, Indian Medical Parliamentarians Forum